Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Among HIV-Negative Participants Using Tenofovir/Emtricitabine-Based Preexposure Prophylaxis in 2020: A Substudy of the French National Agency for Research on AIDS and Viral Hepatitis PREVENIR and Inserm SAPRIS-Sero Cohorts

Autor: Delaugerre, Constance1,2 (AUTHOR) constance.delaugerre@aphp.fr, Assoumou, Lambert3 (AUTHOR), Maylin, Sarah1 (AUTHOR), Minier, Marine1 (AUTHOR), Gabassi, Audrey1 (AUTHOR), Genin, Michèle3 (AUTHOR), Beniguel, Lydie3 (AUTHOR), Ghosn, Jade4 (AUTHOR), Lamballerie, Xavier de5 (AUTHOR), Mouhebb, Mayssam El3 (AUTHOR), Costagliola, Dominique3 (AUTHOR), Carrat, Fabrice3,6 (AUTHOR), Molina, Jean Michel2,7 (AUTHOR), Groups, for the PREVENIR and SAPRIS-Sero Study (AUTHOR)
Zdroj: Open Forum Infectious Diseases. Jul2022, Vol. 9 Issue 7, p1-4. 4p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje